Reduction in normalized bone elasticity following long-term bisphosphonate treatment as measured by ultrasound critical angle reflectometry.
Using an improved version of ultrasound critical angle reflectometry, the bone quality of cortical and trabecular bone was assessed in vivo by measuring elastic moduli (normalized for bone density) at both principal axes, referred to as the minimum and maximum normalized elasticities. The measurements were made in 30 normal premenopausal women, 30 normal postmenopausal women, 22 untreated postmenopausal women with osteoporosis, 74 postmenopausal women with osteoporosis or osteopenia on bisphosphonate treatment, and 32 patients with renal transplantation (16 women and 16 men) taking steroids. Cortical elasticity was higher than trabecular elasticity; both declined slightly and non-significantly with age in normal women. Among untreated postmenopausal women with osteoporosis, cortical maximum normalized elasticity (E(cmax)) remained within 95% prediction intervals of normal women. Among patients on bisphosphonate, E(cmax) was low in the majority of patients. E(cmax) was significantly more depressed among those taking the drug > or =3 years than <3 years (22.1% below normal premenopausal women versus 17.2%, P =0.001), and among those with incident non-spinal fractures than without (75.9 vs. 81.5%, P =0.008). E(cmax) was independent of bone mineral density at the calcaneus. Most patients with renal transplantation had low E(cmax), with a mean 20.8% below the normal premenopausal mean. Qualitatively similar findings were found with cortical minimum elasticity and with trabecular minimum and maximum elasticities. Thus, the material bone quality of cortical and trabecular bone may be impaired following bisphosphonate treatment, as in renal transplantation on steroids.
Richer
Edmond
E
Advanced Radiological Sciences Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. edmond.richer@utsouthwestern.edu
Lewis
Matthew A
MA
Odvina
Clarita V
CV
Vazquez
Miguel A
MA
Smith
Billy J
BJ
Peterson
Roy D
RD
Poindexter
John R
JR
Antich
Peter P
PP
Pak
Charles Y C
CY
D000328:Adult; D000368:Aged; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001851:Bone Diseases, Metabolic / Q000000981:diagnostic imaging / Q000503:physiopathology; D002111:Calcaneus / Q000000981:diagnostic imaging / Q000503:physiopathology; D004164:Diphosphonates / Q000009:adverse effects*; D004548:Elasticity; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000503:physiopathology; D013256:Steroids / Q000627:therapeutic use; D014129:Trabecular Meshwork / Q000000981:diagnostic imaging / Q000503:physiopathology; D014463:Ultrasonography / Q000379:methods
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D013256:Steroids
J Biomech. 1994 Sep;27(9):1195-9
7929470
J Orthop Res. 2004 May;22(3):465-71
15099622
Bone. 1998 Sep;23(3):303-6
9737354
J Bone Miner Res. 1992 Sep;7(9):1071-9
1414499
Bone. 2000 Nov;27(5):687-94
11062357
N Engl J Med. 1995 Nov 30;333(22):1437-43
7477143
JAMA. 1999 Oct 13;282(14 ):1344-52
10527181
Ann N Y Acad Sci. 1990;592:307-25; discussion 334-45
2197949
J Bone Miner Res. 1991 Apr;6(4):417-26
1858525
J Biomech. 1987;20(10):979-86
3693379
Phys Med Biol. 1997 Sep;42(9):1763-77
9308082
J Bone Miner Res. 1993 Mar;8(3):301-11
8456586
Bone. 2001 May;28(5):524-31
11344052
J Oral Maxillofac Surg. 2004 May;62(5):527-34
15122554
JAMA. 2001 Feb 14;285(6):785-95
11176917
N Engl J Med. 2003 Jul 31;349(5):457-63
12890844
J Bone Miner Res. 1998 Jan;13(1):114-21
9443797
Osteoporos Int. 2004 Feb;15(2):160-7
14666400
Nephron. 2001 Jun;88(2):97-106
11399910
Ultrasound Med Biol. 2001 Jun;27(6):861-7
11516546